About Sophie Jamal
Abida Sophie Jamal is a Canadian endocrinologist and former osteoporosis researcher who was at the centre of a scientific misconduct case in the mid-to-late 2010s. Jamal published a high-profile paper suggesting that the heart medication nitroglycerin was a treatment for osteoporosis, and was later demonstrated to have misrepresented her results. She received a lifetime ban from receiving funding from the Canadian Institutes of Health Research and was named directly in their disclosure report, becoming the first person mentioned by name by the institute for scientific misconduct. Jamal was later stripped of her medical license for two years, regaining it in a controversial 3–2 decision. Her first trial to test a nitrate drug against placebo was published in 2004 and had positive findings. She was also awarded the 2012 CSEM Young Investigator Award, a CA$20,000 grant from the Canadian Society of Endocrinology and Metabolism. She became the first scientist mentioned by name by the institute for fraud, which had previously redacted the names of sanctioned researchers for confidentiality reasons.
Biography source: Wikipedia. The profile adds birthday-specific historical context from the Celebs Birthday Today editorial database.